Evidence map›Paper›PMID 41253176›Full record

ArticleBone & joint open2025

The Evaluation Measure for BRACe Experience (EMBRACE): developing a patient-reported outcome measure for infants with hip dysplasia.

Joanna Craven, Wesley W E S Theunissen, Oliver Lane, Sara Beattie, Xavier L Griffin, Daniel C Perry

Abstract read
In one paragraph

Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joanna CravenUniversity of Liverpool, Liverpool, UK.
Wesley W E S TheunissenDepartment of Orthopedic Surgery & Trauma, Máxima Medical Center, Veldhoven, The Netherlands.
Oliver LaneUniversity Hospital of Wales, Cardiff, UK.
Sara BeattieMersey Deanery, Liverpool, UK.
Xavier L GriffinQueen Mary University of London, London, UK.
Daniel C PerryUniversity of Liverpool, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To identify or develop a patient-reported outcome measure (PROM) aligned with the family-centred core outcome set (COS) for infants with developmental dysplasia of the hip (DDH) treated in a brace. Methods: This study was conducted in five phases: 1) identification of relevant PROMs through two systematic literature reviews; 2) assessment of identified PROMs for content validity and relevance to the COS; 3) a consensus meeting with key stakeholders, including parents and clinicians; 4) development of a novel PROM; and 5) pilot testing with parents of infants treated in a brace. PROMs were assessed according to COSMIN criteria, and development was guided by stakeholder feedback. Results: The systematic reviews identified two relevant PROMs: the Hip Worries Inventory (HWI) and the Infant and Toddler Quality of Life Questionnaire (ITQOL). Neither tool fully aligned with the COS, nor was considered suitable for comprehensive assessment in this population. The HWI was judged to lack domain coverage and negatively framed items, whereas the ITQOL was lengthy and burdensome. A consensus meeting supported the development of a new, concise PROM. The resulting Evaluation Measure for BRACe Experience (EMBRACE) includes eight items, scored using a Likert scale, across caregiver and infant domains. Pilot testing confirmed acceptability, clarity, and relevance. Conclusion: The EMBRACE is a concise, family-centred PROM developed to reflect the core domains that were prioritized by families and clinicians for children undergoing DDH brace treatment. It enables the impact of treatment to be captured on both infants and caregivers.

Identifiers

PMID41253176
PMCPMC12626650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.